Literature DB >> 6118432

In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure.

T P Kenakin, D Beek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6118432

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  9 in total

1.  Affinities of full agonists for cardiac beta-adrenoceptors calculated by use of in vitro desensitization.

Authors:  M L Herepath; K J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

2.  Study of ridazolol on isolated canine and human coronary arteries.

Authors:  P Unger; G Berkenboom; J Fontaine
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

3.  Desensitization and functional antagonism by beta-adrenoceptor and muscarinic receptor agonists, respectively: a comparison with receptor alkylation for calculation of apparent agonist affinity.

Authors:  R M Eglen; W W Montgomery; R L Whiting
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

4.  Effects of prenalterol and its N-homoveratryl derivative in the anaesthetized cat.

Authors:  C Maccarrone; E Malta; C Raper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-07       Impact factor: 3.000

5.  The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors.

Authors:  T P Kenakin
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

6.  Effects of in vivo treatment with isoprenaline or prenalterol on beta-adrenoceptor mechanisms in the heart and soleus muscle of the cat.

Authors:  A Hedberg; H Mattsson; V Nerme; E Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

7.  Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.

Authors:  S Rasmussen; P F Høilund-Carlsen; B Hesse; O J Hartling; J Fabricius; H Dige-Petersen; J Giese
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Systematic errors in detecting biased agonism: Analysis of current methods and development of a new model-free approach.

Authors:  H Ongun Onaran; Caterina Ambrosio; Özlem Uğur; Erzsebet Madaras Koncz; Maria Cristina Grò; Vanessa Vezzi; Sudarshan Rajagopal; Tommaso Costa
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

9.  Pharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2.

Authors:  D Malfacini; C Ambrosio; M C Gro'; M Sbraccia; C Trapella; R Guerrini; M Bonora; P Pinton; T Costa; G Calo'
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.